Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
July 17, 2024
Designed for fellows, practicing endocrinologists, and healthcare professionals, EBR 2024 ensures you are well-prepared for board certification. The program guarantees a pass or offers free registration for EBR 2025. Participants receive the Endocrine Board Review (EBR) 2024 16th Edition book, access to interactive practice exams, and expert-led Q&A sessions. The preparation covers clinical scenarios aligned with the ABIM exam blueprint. Register by Monday, August 5, to secure the best rates.
June 18, 2024
Share your preferences for symposium proposals or session suggestions. Even partial ideas will be further developed by our Annual Meeting Steering Committee. We are accepting ideas through 1 PM ET on Monday, July 29.
June 12, 2024
Our new AI in Healthcare Virtual Summit, taking place online November 8-9, will inform providers, healthcare professionals, researchers, technologists, industry stakeholders, and educators on the capabilities of AI in the healthcare field. Learn from experts how AI technologies are redefining diagnostics, treatment planning, and patient outcomes in healthcare in addition to exploring the latest advancements in AI-driven healthcare, from predictive analytics to machine learning algorithms. Register by Saturday, August 31 to take advantage of our best available rates.
June 12, 2024
The 1st International Conference on Steroid Hormones and Receptors (SHR 2024) will be held from October 16-18, in Albuquerque, NM, at the University of New Mexico Comprehensive Cancer Center. Join meeting chairs Eric Prossnitz (University of New Mexico) and Endocrine Society incoming President Carol Lange (University of Minnesota) for an innovative agenda covering advances in steroid hormone action in biology and medicine, exploring their role in biology, chemistry, pharmacology, oncology, neurology, metabolism, cardiovascular biology and endocrinology. Learn more and register today.
July 26, 2024
Among our advocacy efforts this week, we urged lawmakers to reject the latest NIH Funding Bill before the US House of Representatives, and endorsed the Access to Birth Control Act. Read our summary of CMS’s proposed rule for the CY 2025 Medicare Physician Fee Schedule (MPFS).
Need more info?
Learn more about the advantages of membership
July 22, 2024
The Endocrine Society’s Chief Policy Officer will be among the speakers at House Appropriations Committee Ranking Member Rosa DeLauro’s (CT-03) press conference to highlight the dangers of 2025 federal government funding proposals that would cut funding for biomedical research and public health.
June 11, 2024
The Endocrine Society endorses the Right to IVF Act, which was introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA) and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF), and urges the Senate to pass the Right to IVF Act on June 12th to ensure that the freedom to start and grow a family is protected and accessible to everyone in the United States.
June 03, 2024
Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society. For children, pregnant people, adults older than 75 years and adults with high-risk prediabetes, the guideline recommends vitamin D higher than the IOM recommended daily allowance.
July 23, 2024
The authors present the case of a 20-year-old woman with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD), with uncontrolled hyperandrogenemia despite supraphysiological glucocorticoid therapy.
July 23, 2024
This first European Society of Endocrinology/Endocrine Society joint clinical practice guideline provides guidance on glucocorticoid-induced adrenal insufficiency to aid clinicians involved in the care of patients on chronic glucocorticoid therapy.
July 23, 2024
We will offer guidance on strategies to facilitate an accurate and timely diagnosis of primary aldosteronism together with a discussion of treatment targets which should be achieved for optimal patient outcomes.
